NO993948L - Anvendelse av aryl-cykloheksylamin-derivater mot CNS- forstyrrelser - Google Patents

Anvendelse av aryl-cykloheksylamin-derivater mot CNS- forstyrrelser

Info

Publication number
NO993948L
NO993948L NO993948A NO993948A NO993948L NO 993948 L NO993948 L NO 993948L NO 993948 A NO993948 A NO 993948A NO 993948 A NO993948 A NO 993948A NO 993948 L NO993948 L NO 993948L
Authority
NO
Norway
Prior art keywords
lower alkyl
aryl
cns disorders
ch2oh
tetrahydronaphthyl
Prior art date
Application number
NO993948A
Other languages
English (en)
Norwegian (no)
Other versions
NO993948D0 (no
Inventor
Alexander Alanine
Bernd Buettelmann
Emmanuel Pinard
Rene Wyler
Marie-Paule Heitz Neidhart
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of NO993948D0 publication Critical patent/NO993948D0/no
Publication of NO993948L publication Critical patent/NO993948L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/451—Non condensed piperidines, e.g. piperocaine having a carbocyclic group directly attached to the heterocyclic ring, e.g. glutethimide, meperidine, loperamide, phencyclidine, piminodine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/138—Aryloxyalkylamines, e.g. propranolol, tamoxifen, phenoxybenzamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/18—Sulfonamides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/357—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having two or more oxygen atoms in the same ring, e.g. crown ethers, guanadrel
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Emergency Medicine (AREA)
  • Psychology (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Heterocyclic Compounds That Contain Two Or More Ring Oxygen Atoms (AREA)
NO993948A 1998-08-18 1999-08-17 Anvendelse av aryl-cykloheksylamin-derivater mot CNS- forstyrrelser NO993948L (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP98115484 1998-08-18

Publications (2)

Publication Number Publication Date
NO993948D0 NO993948D0 (no) 1999-08-17
NO993948L true NO993948L (no) 2000-02-21

Family

ID=8232474

Family Applications (1)

Application Number Title Priority Date Filing Date
NO993948A NO993948L (no) 1998-08-18 1999-08-17 Anvendelse av aryl-cykloheksylamin-derivater mot CNS- forstyrrelser

Country Status (24)

Country Link
US (1) US6184236B1 (de)
JP (1) JP3455142B2 (de)
KR (1) KR100341194B1 (de)
CN (1) CN1141936C (de)
AR (1) AR021770A1 (de)
AT (1) ATE326219T1 (de)
AU (1) AU756408B2 (de)
BR (1) BR9903779A (de)
CA (1) CA2280455A1 (de)
DE (1) DE69931316D1 (de)
HR (1) HRP990256A2 (de)
HU (1) HUP9902737A3 (de)
ID (1) ID23107A (de)
IL (1) IL131399A0 (de)
MA (1) MA26677A1 (de)
MY (1) MY133133A (de)
NO (1) NO993948L (de)
NZ (1) NZ337243A (de)
PE (1) PE20000955A1 (de)
PL (1) PL334949A1 (de)
SG (1) SG82014A1 (de)
TR (1) TR199902015A2 (de)
YU (1) YU38699A (de)
ZA (1) ZA995212B (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE301642T1 (de) * 2000-06-06 2005-08-15 Warner Lambert Co Bicyclische cyclohexylamine und ihre verwendung als nmda-rezeptor antagonisten
JP2005506292A (ja) * 2001-03-08 2005-03-03 エモリー ユニバーシティ pHに依存するNMDAレセプターアンタゴニスト
DE10153345A1 (de) * 2001-10-29 2003-05-08 Gruenenthal Gmbh Substituierte 1H-Chinoxalin-2-on-Verbindungen und substituierte 4-Aryl- und 4-Heteroarylcyclohexan-Verbindungen
US20070004805A1 (en) * 2005-07-01 2007-01-04 Navinta Llc Process for preparation of liquid dosage form containing sodium 4-phenylbutyrate
KR20100045983A (ko) 2007-06-29 2010-05-04 에모리 유니버시티 신경보호를 위한 nmda 수용체 길항물질

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4032766A1 (de) 1990-10-16 1992-04-30 Basf Ag Phenylpiperidinoylamine und diese enthaltende arzneimittel
EP0503411B1 (de) 1991-03-14 1995-11-29 BASF Aktiengesellschaft Substituierte N-Phenylpiperidine und Arzneimittel daraus
DE4117904A1 (de) 1991-05-31 1992-12-03 Basf Ag Substituierte n-phenylpiperidine
CZ126598A3 (cs) * 1995-10-26 1998-09-16 Mitsubishi-Tokyo Pharmaceuticals, Inc. Fenylethanolaminové sloučeniny, způsob jejich výroby a farmaceutické prostředky s jejich obsahem

Also Published As

Publication number Publication date
NO993948D0 (no) 1999-08-17
US6184236B1 (en) 2001-02-06
JP2000109429A (ja) 2000-04-18
AR021770A1 (es) 2002-08-07
PL334949A1 (en) 2000-02-28
CN1141936C (zh) 2004-03-17
HUP9902737A2 (hu) 2000-06-28
HU9902737D0 (en) 1999-10-28
JP3455142B2 (ja) 2003-10-14
NZ337243A (en) 2000-12-22
KR100341194B1 (ko) 2002-06-20
MY133133A (en) 2007-10-31
IL131399A0 (en) 2001-01-28
ZA995212B (en) 2000-02-18
CA2280455A1 (en) 2000-02-18
DE69931316D1 (de) 2006-06-22
CN1248439A (zh) 2000-03-29
TR199902015A3 (tr) 2000-03-21
MA26677A1 (fr) 2004-12-20
YU38699A (sh) 2002-03-18
ATE326219T1 (de) 2006-06-15
TR199902015A2 (xx) 2000-03-21
KR20000017343A (ko) 2000-03-25
PE20000955A1 (es) 2000-09-28
AU4453799A (en) 2000-05-04
ID23107A (id) 2000-02-24
BR9903779A (pt) 2000-09-19
SG82014A1 (en) 2001-07-24
HUP9902737A3 (en) 2001-01-29
AU756408B2 (en) 2003-01-09
HRP990256A2 (en) 2000-04-30

Similar Documents

Publication Publication Date Title
BR9812046A (pt) Compostos, processos para a preperação do composto e para tratar um paciente humano ou animal, composição farmacêutica, e, uso de um composto
DK624687A (da) Farmaceutisk praeparat indeholdende imidazolderivater
EA200200446A1 (ru) НОВЫЕ α-АМИНОКИСЛОТНЫЕ СОЕДИНЕНИЯ, СПОСОБ ИХ ПОЛУЧЕНИЯ И ФАРМАЦЕВТИЧЕСКИЕ КОМПОЗИЦИИ, ИХ СОДЕРЖАЩИЕ
GB2188234A (en) Obesity treating agents
SE0104334D0 (sv) Therapeutic agents
ATE315022T1 (de) Prostaglandinanaloga als ep4-rezeptoragonisten
ATE512961T1 (de) Amorphes nebivolol hydrochlorid und seine herstellung
IT1250049B (it) Composti triciclici.
RU99101081A (ru) Режим введения ингибиторов н+, к+-атфазы
NO20052730L (no) Aminoalkosyindoler som 5-HT6-reseptorligander for behandling av CNS-lidelser
DK160686A (da) Tri- og tetracycliske forbindelser
EP0982026A3 (de) Verwendung von Aryl-Cyclohexylamine Derivaten zur Herstellung von NMDA-Rezeptorblockern
DK0871626T3 (da) Triazoloner som apolipoprotein-B syntheseinhibitorer
NZ337243A (en) Use of aryl-cyclohexylamine derivatives as NMDA (N-methyl-D-aspartate) receptor subtype selective blockers against CNS disorders
KR940009179A (ko) 벤조푸란 유도체, 그의 제조 방법, 그를 함유한 제약조성물 및 그의 의약으로서의 용도
DK0516350T3 (da) 2-hydroxy-2-phenylethylamin-derivater som beta-3-adrenoceptoragonister
TR199801774T2 (xx) 4-fenil-3, 6-dihidro-2H- piridil t�revlerinin, NMDA resept�r alttip blokerleri olarak kullan�m�.
DE3470883D1 (en) Tetrahydroisoxazolo(4,5-c)pyridine derivatives and preparation thereof
ES343818A1 (es) Procedimiento para la obtencion de nuevas 3-amino - sidno- minas sustituidas.
IL87174A (en) Benzimidazole derivatives, their preparation and pharmaceutical compositions containing them
CZ30097A3 (en) Novel streptogramin derivatives, process of their preparation and pharmaceutical composition containing thereof
ECSP993105A (es) El uso de los derivados de aril- ciclohexilamina contra transtornos del sistema nervioso central
AR030410A1 (es) Derivados de 2-fenilpiran-4-ona, proceso para obtener dichos derivados, composiciones farmaceuticas que comprenden los derivados mencionados y el uso de los mismos en la manufactura de medicamentos
KR830000903A (ko) 고혈압과 장장애를 억제하는 방법과 조성물
JPH0456009B2 (de)